Bionoid Pharma, Inc.
BINP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $16,630 | $19,541 | $67,493 | $92,583 |
| - Cash | $0 | $3 | $2 | $23 |
| + Debt | $0 | $155 | $155 | $155 |
| Enterprise Value | $16,630 | $19,693 | $67,646 | $92,715 |
| Revenue | $0 | $38 | $36 | $102 |
| % Growth | -100% | 4.1% | -64.7% | – |
| Gross Profit | -$277 | $8 | $17 | $46 |
| % Margin | – | 22.4% | 48.1% | 45.1% |
| EBITDA | $555 | -$4 | $5 | -$132 |
| % Margin | – | -11.5% | 13.5% | -129.3% |
| Net Income | -$317 | $12 | $1 | -$135 |
| % Margin | – | 31.3% | 4.1% | -132.2% |
| EPS Diluted | -0.005 | -0 | 0 | -0.003 |
| % Growth | -4,900% | – | 100% | – |
| Operating Cash Flow | – | $0 | -$21 | -$19 |
| Capital Expenditures | – | $0 | $0 | -$0 |
| Free Cash Flow | – | $0 | -$21 | -$19 |